Cure My Disease

Don't miss your cure!

 Log in / Sign up

Two shoulder implants, one question: which restores function best?

NCT ID NCT07815535

Knowledge-focused Sponsor: Vani Sabesan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are comparing two common types of total shoulder replacement, anatomic and reverse, in adults who already had the surgery. The study tracks patient-reported pain and function scores, complications, and revision surgeries for three years. They also check how often the implant used during surgery differed from the preoperative 3D surgical plan, and whether those differences relate to outcomes. Participants' existing medical records are reviewed, and some may complete a one-time questionnaire by phone or online.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one implant design clearly outperforms the other for certain shoulders, surgeons could match patients to the replacement type most likely to restore pain-free function.
What could go wrong
This observational study follows people who already had surgery, so it can show links but not prove one implant causes better results. Findings may not apply to everyone, and some participants may be lost to follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible patients will be identified from a cohort of individuals who underwent either a total or reverse shoulder arthroplasty from 2020-2024 using a single innovative implant system, with a target enrollment of 300 patients. The cohort will include patients from participating sites and the data collected will be deidentified.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primary shoulder arthroplasty * Age \>18 years at the time of surgery * At least 2 years from the date of surgery Exclusion Criteria: * Revision shoulder arthroplasty * Acute fracture cases * Inability to obtain consent for outcome collection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arthritis shoulder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritic joint disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arthritis shoulder Arthroplasty, replacement, shoulder Rotator cuff arthropathy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kansas City Orthopaedic Alliance

    Leawood, Kansas, 66224, United States

  • Sabesan Orthopaedics Research Inc

    Atlantis, Florida, 33462, United States

  • Somers Orthopaedic Surgery & Sports Medicine Group

    Carmel, New York, 10512, United States

  • Steindler Orthopaedic Clinic

    North Liberty, Iowa, 52317, United States

  • Tennessee Orthopaedic Alliance

    Columbia, Tennessee, 38401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.